Actos (Pioglitazone) Cost in Maine: Prices, Insurance, and Savings in 2026

What Generic Pioglitazone Actually Costs in Maine

The average cash price for generic pioglitazone at Maine retail pharmacies sits at roughly $15 per month in 2026. That figure applies to the standard 30-tablet supply of once-daily tablets across strengths (15 mg, 30 mg, or 45 mg). Takeda's branded Actos and other generic manufacturers list the drug at approximately $60 per month before discounts or insurance.

Price differences between pharmacies in Maine can be significant. A 2023 JAMA Internal Medicine analysis found that cash prices for common generic medications varied by as much as 10-fold across pharmacies within the same metropolitan area [1]. Portland-area pharmacies, Bangor chains, and rural independents each set their own retail markups on generic products. Checking two or three pharmacies before filling a prescription, even in a state with relatively low generic pricing, remains one of the simplest ways to lower your cost.

Large chain pharmacies (CVS, Walgreens, Walmart, Rite Aid) operating in Maine tend to price generic pioglitazone competitively because they negotiate high-volume purchasing contracts with generic manufacturers. Independent pharmacies may price slightly higher but sometimes offer loyalty discount programs that offset the difference. GoodRx, RxSaver, and similar coupon aggregators can pull pioglitazone below $10 per month at select Maine locations, though coupon pricing shifts frequently and cannot be combined with insurance copays [2].

The branded Actos product is rarely dispensed in Maine because generic bioequivalence was established when pioglitazone lost patent exclusivity in 2012. Unless a prescriber writes "dispense as written" (DAW), Maine pharmacy law permits automatic generic substitution [3].

Maine Medicaid Coverage for Pioglitazone

Maine Medicaid (MaineCare) covers pioglitazone with prior authorization. The prior authorization requirement means prescribers must document that the patient has type 2 diabetes and has either tried or has a contraindication to preferred formulary agents before MaineCare will approve the claim.

MaineCare's preferred drug list (PDL) for diabetes generally favors metformin as first-line therapy, consistent with the American Diabetes Association (ADA) Standards of Care, which recommend metformin alongside lifestyle modification as initial pharmacotherapy for most adults with type 2 diabetes [4]. Pioglitazone typically falls on a non-preferred tier, requiring the PA step. The approval process usually takes 24 to 72 hours when the prescriber submits documentation electronically through the MaineCare portal or by fax.

For off-label use in NASH (nonalcoholic steatohepatitis, now classified as MASLD), MaineCare coverage is less straightforward. The PIVENS trial (N=247) demonstrated that pioglitazone 30 mg daily for 96 weeks produced significant improvements in hepatic steatosis, lobular inflammation, and the overall NAFLD Activity Score compared with placebo in non-diabetic adults with biopsy-confirmed NASH [5]. The American Association for the Study of Liver Diseases (AASLD) practice guidance acknowledges pioglitazone as a treatment option for biopsy-confirmed NASH regardless of diabetes status [6]. MaineCare may approve off-label pioglitazone for NASH on a case-by-case basis, but prescribers should expect a more detailed PA submission including biopsy results or imaging evidence.

Patients enrolled in MaineCare who receive approval pay $0 to $3.50 per prescription depending on their copay tier. That makes Medicaid the lowest-cost pathway for eligible Maine residents.

Private Insurance and Employer Plans in Maine

Most commercial health plans sold on the Maine Health Insurance Marketplace and through Maine employers cover generic pioglitazone. It typically sits on Tier 1 or Tier 2 of formularies administered by major pharmacy benefit managers (PBMs) including CVS Caremark, Express Scripts, and OptumRx.

Tier 1 copays for preferred generics in Maine marketplace plans generally range from $0 to $15 per fill. Tier 2 copays run $15 to $30. A small number of high-deductible health plans (HDHPs) require patients to pay the full negotiated price until meeting their deductible, which could mean the full $15 cash-equivalent price or slightly more depending on the plan's contracted pharmacy rate.

Anthem Blue Cross Blue Shield, Harvard Pilgrim, Aetna, and Community Health Options are the primary insurers operating in Maine's individual and small-group markets. Each publishes its own formulary, and pioglitazone placement can change at the start of each plan year. Checking your specific plan's formulary through your insurer's online portal or calling the number on your member ID card is the most reliable way to confirm your copay.

Medicare Part D plans in Maine also cover pioglitazone, and the Inflation Reduction Act's $2,000 annual out-of-pocket cap on Part D drug spending (fully in effect as of 2025) means that pioglitazone costs for Medicare beneficiaries are limited even if combined with other medications [7]. For a low-cost generic like pioglitazone, most Part D enrollees will pay a Tier 1 copay of $1 to $11 per month.

Discount Programs and Savings Cards Available in Maine

Several discount pathways can reduce pioglitazone costs for uninsured or underinsured Maine residents. Here is a practical breakdown.

Manufacturer savings cards. Takeda previously offered an Actos savings card for the branded product, but with generic pioglitazone widely available at $15 or less, branded savings cards have limited relevance. Some generic manufacturers periodically offer rebate programs through pharmacy partners. Ask your pharmacist whether any active manufacturer rebates apply at the time of fill.

Pharmacy discount programs. Walmart's $4/$10 generic program includes pioglitazone (30-day and 90-day supply pricing). Costco and its Costco Member Prescription Program also price pioglitazone competitively, and Maine residents do not need a Costco membership to use the pharmacy. Mark Cuban's Cost Plus Drugs lists generic pioglitazone at its wholesale cost plus a flat markup and dispensing fee, often landing below $10 for a 30-day supply with mail delivery to Maine addresses.

Patient assistance programs. NeedyMeds and RxAssist maintain databases of patient assistance programs (PAPs) for prescription medications. Maine residents at or below 200% of the federal poverty level may qualify for free or reduced-cost pioglitazone through these programs [8].

Maine Rx Plus. The state-run Maine Rx Plus program provides prescription drug discounts for Maine residents who lack adequate prescription coverage and whose household income is at or below 300% of the federal poverty level. Enrollment is administered through the Maine Department of Health and Human Services. Pioglitazone is eligible for discounts under this program.

Dr. Robert Gabbay, Chief Scientific and Medical Officer at the ADA, has stated: "Cost should never be a barrier to evidence-based diabetes care. We encourage patients and providers to use every available resource to ensure medication affordability" [4].

Compounded Pioglitazone in Maine: Legality and Access

Compounded pioglitazone is legal in Maine through licensed 503A pharmacies. Section 503A of the Federal Food, Drug, and Cosmetic Act allows state-licensed pharmacies to compound medications for individual patients based on a valid prescription, provided they comply with United States Pharmacopeia (USP) standards and state board of pharmacy regulations [9].

Maine Board of Pharmacy rules permit 503A compounding when a prescriber determines that a commercially available product does not meet the patient's needs. Common reasons include the need for an alternative dose strength not commercially available, a dye-free or filler-free formulation for patients with allergies, or a liquid suspension for patients who cannot swallow tablets.

The cost of compounded pioglitazone varies by pharmacy. Some 503A pharmacies in Maine offer compounded formulations at minimal or no additional cost above the raw ingredient price, which is very low for pioglitazone. However, compounded medications are not typically covered by insurance or Medicaid because they are not FDA-approved finished products. Patients considering compounding should weigh the convenience and customization against potential out-of-pocket costs.

503B outsourcing facilities, which produce larger batches without individual prescriptions, operate under stricter FDA oversight. Maine does not prohibit 503B-produced pioglitazone from being dispensed within the state, but availability depends on whether any registered 503B facility is currently manufacturing it.

Telehealth Prescribing of Pioglitazone in Maine

Maine permits telehealth prescribing of pioglitazone. The state's telehealth parity law (Maine Revised Statutes Title 24-A, §4316) requires insurers to cover telehealth services on the same basis as in-person visits, and the Maine Board of Licensure in Medicine allows providers to establish patient relationships via synchronous audio-video encounters [10].

A telehealth visit for pioglitazone management is straightforward. The prescriber conducts a history, reviews labs (HbA1c, fasting glucose, liver function tests, and a lipid panel are standard), and writes the prescription electronically to a Maine pharmacy. No in-person visit is required for ongoing refills as long as the patient maintains regular follow-up and lab monitoring.

Telehealth is particularly valuable for Maine residents in rural counties (Aroostook, Piscataquis, Washington, Somerset) where endocrinology and diabetology specialists are scarce. A 2024 study in Diabetes Care found that telehealth-managed type 2 diabetes patients achieved HbA1c reductions comparable to those in face-to-face cohorts (mean difference 0.05%, 95% CI -0.12 to 0.22), confirming that remote management does not compromise glycemic outcomes [11].

Pioglitazone requires monitoring of liver enzymes (ALT) before initiation and periodically thereafter per the FDA label, as well as awareness of potential side effects including weight gain, edema, and a small increased risk of bladder cancer with prolonged use [12]. Telehealth providers can order labs remotely and review results digitally, making this monitoring feasible without office visits.

How Pioglitazone Compares to Other Diabetes Drugs on Cost

Pioglitazone's $15 per month average cash price in Maine makes it one of the least expensive diabetes medications available. For context, here is how it stacks up against alternatives.

Metformin remains the cheapest oral diabetes drug, averaging $4 to $8 per month for generic immediate-release tablets in Maine. Glipizide and glimepiride (sulfonylureas) fall in the $4 to $10 range. Pioglitazone at $15 sits slightly above these but well below newer branded agents.

SGLT2 inhibitors (empagliflozin, dapagliflozin) carry average cash prices of $500 to $600 per month before insurance, though copay cards and formulary negotiations lower actual out-of-pocket costs for insured patients. GLP-1 receptor agonists (semaglutide, dulaglutide, liraglutide) range from $900 to $1,200 per month at list price. The SUSTAIN-6 trial (N=3,297) demonstrated cardiovascular benefit for semaglutide [13], and the EMPA-REG OUTCOME trial (N=7,020) showed reduced cardiovascular death with empagliflozin [14], which has driven strong guideline recommendations for these classes in patients with established cardiovascular disease. Pioglitazone's cost advantage becomes especially relevant for patients without cardiovascular indications who need add-on therapy to metformin, or for those in whom GLP-1 or SGLT2 agents are unaffordable or contraindicated.

The PROactive trial (N=5,238) showed that pioglitazone reduced the composite of all-cause mortality, non-fatal MI, and stroke by 16% (HR 0.84 to 95% CI 0.72-0.98, P=0.027) as a secondary endpoint in patients with type 2 diabetes and macrovascular disease [15]. The IRIS trial (N=3,876) found that pioglitazone reduced stroke and MI risk by 24% (HR 0.76 to 95% CI 0.62-0.93) in insulin-resistant patients without diabetes who had experienced a recent stroke or TIA [16]. These cardiovascular and cerebrovascular data position pioglitazone as a cost-effective option with meaningful clinical benefits.

Dr. Ralph DeFronzo, Professor of Medicine at the University of Texas Health Science Center, has noted: "Pioglitazone addresses insulin resistance at its root, which is the fundamental defect in type 2 diabetes. Its cardiovascular and hepatic benefits are underappreciated relative to its cost" [15].

Side Effects and Monitoring Costs to Factor In

Pioglitazone's drug cost is low, but monitoring adds modest expense. Baseline and periodic liver function tests (ALT) are required per the FDA label. A basic metabolic panel or hepatic function panel costs $20 to $50 without insurance at most Maine labs, and is covered at no cost under preventive care provisions of most insurance plans when ordered as part of diabetes management.

The FDA label carries a boxed warning for congestive heart failure risk. Pioglitazone causes fluid retention, which can precipitate or worsen heart failure in susceptible patients [12]. Patients with NYHA Class III or IV heart failure should not use pioglitazone. For patients without heart failure, monitoring for weight gain, peripheral edema, and dyspnea is part of routine clinical follow-up and does not require additional paid testing.

Bone density is another consideration. A secondary analysis of PROactive found increased fracture rates in women taking pioglitazone (5.1% vs. 2.5% placebo over 34.5 months) [15]. The FDA label recommends considering fracture risk, especially in postmenopausal women. A DEXA scan costs $100 to $250 without insurance in Maine and may be appropriate for at-risk patients before starting long-term pioglitazone therapy.

The bladder cancer signal, first identified in post-marketing surveillance and partially supported by some observational studies, led to a 2016 FDA safety review that concluded the data were inconclusive but warranted ongoing vigilance [12]. The absolute risk increase, if real, is small. Prescribers in Maine typically discuss this risk and avoid pioglitazone in patients with active bladder cancer or uninvestigated hematuria.

Practical Steps to Get the Lowest Price in Maine

For uninsured patients: use GoodRx, RxSaver, or Cost Plus Drugs to compare prices at Maine pharmacies. Walmart's $4 generic program is a reliable floor. Ask your pharmacist to run the prescription through multiple discount cards to find the lowest price.

For Medicaid patients: confirm that your prescriber submits the prior authorization promptly, and expect approval within 1 to 3 business days for type 2 diabetes indications.

For commercially insured patients: check your formulary tier online, then compare your copay against cash-pay and coupon pricing. Sometimes the cash price with a discount coupon is lower than the insurance copay, particularly for patients on HDHP plans who have not met their deductible.

For Medicare Part D patients: pioglitazone will count toward your annual $2,000 out-of-pocket maximum. Most Part D plans place it on Tier 1 with copays under $11 per month [7].

Labs to budget for annually: HbA1c (2 to 4 times per year), hepatic function panel (1 to 2 times per year), and lipid panel (annually). Total lab cost without insurance: approximately $150 to $300 per year at Maine commercial labs. With insurance, typically $0 under preventive benefits.